MORTON M. HALPERN, M.D.; LOUIS LEMBERG, M.D.; MARTIN BELLE, M.D.; HERBERT EICHERT, M.D., F.A.C.P.
Reliable evidence accumulated in the last 10 years has indicated that anticoagulants are of decided value in the prevention and treatment of thromboembolic diseases. Beginning with Wright's report in 1945,1 the specific value of anticoagulants in the management of acute myocardial infarction has been adequately demonstrated by many investigators.
The advisability of instituting anticoagulant therapy in every case of cardiac infarction has been challenged recently.2-5 Inconvenience, expense, and certain known hazards inherent in anticoagulant therapy were stated to outweigh any benefits that might accrue from its use in the so-called "good risk" cases. One report6 goes even further, by concluding
MORTON M. HALPERN, LOUIS LEMBERG, MARTIN BELLE, HERBERT EICHERT. THE SELECTIVE USE OF ANTICOAGULANTS IN ACUTE MYOCARDIAL INFARCTION BASED ON INITIAL PROGNOSIS(THE SELECTIVE USE OF ANTICOAGULANTS IN ACUTE MYOCARDIAL INFARCTION BASED ON INITIAL PROGNOSIS*). Ann Intern Med. 1954;41:942–951. doi: 10.7326/0003-4819-41-5-942
Download citation file:
Published: Ann Intern Med. 1954;41(5):942-951.
Acute Coronary Syndromes, Cardiology, Coronary Heart Disease, Emergency Medicine.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use